Lilly Asia, OrbiMed & Qiming in Brain-Computer Tech
11 Feb 2025
US$ 20.00
Lilly Asia Ventures and the US-based OrbiMed Advisors LLC (OrbiMed) have joined Qiming Venture Partners to co-lead ......
Tag
HealthTech
Related Publications
After successfully winning the two-year-long bidding war with Crescent Capital Partners over the privatisation of ......
Savvy foreign investors are seeking to strengthen their footholds in South Korea where domestic private equity firms ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.